Abstract
The optimal management of screen-detected, localised prostate cancer remains controversial, related to overtreatment issues of screening and the nonrandomised evidence base. Active surveillance (AS) aims to delay or avoid curative therapy but may potentially harm patients' well-being through living with untreated prostate cancer.
Lingua originale | Inglese |
---|---|
pagine (da-a) | 637-645 |
Numero di pagine | 9 |
Rivista | European Urology |
Volume | 67 |
DOI | |
Stato di pubblicazione | Pubblicato - 2015 |
Keywords
- Active surveillance
- Anxiety
- Depression
- Health-related quality of life
- Prostate cancer
- Systematic review
- Well-being